Disease Burden Assessment for Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
(MEASUREAAVitHS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how living with conditions like alopecia areata (patchy hair loss), vitiligo (loss of skin color in patches), and hidradenitis suppurativa (painful skin lumps) affects daily life. Researchers seek insights from individuals with moderate to severe forms of these conditions. Those diagnosed by a doctor with any of these conditions and able to complete study questionnaires might be a good fit for the study.
As an unphased trial, this study offers a unique opportunity to contribute valuable insights that could enhance understanding and management of these conditions.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to understand the disease burden of alopecia areata, vitiligo, and hidradenitis suppurativa. Unlike treatments that focus solely on managing symptoms, this trial seeks to gather comprehensive data on how these conditions impact patients' quality of life. This approach can lead to more targeted therapies and improved patient care by highlighting unmet needs and areas for therapeutic innovation. By focusing on the overall impact of these conditions, the trial has the potential to guide future treatments that are more effective and patient-centered.
Who Is on the Research Team?
ABBVIE INC.
Principal Investigator
AbbVie
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Assessment
Participants' quality of life and disease severity are assessed using various scales such as DLQI, AASIS, SALT, F-VASI, VitiQoL, and IHS4
Follow-up
Participants are monitored for any changes in quality of life and disease severity after initial assessment
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
AbbVie
Lead Sponsor
Dr. Roopal Thakkar
AbbVie
Chief Medical Officer since 2023
MD from Wayne State University School of Medicine
Robert A. Michael
AbbVie
Chief Executive Officer
Bachelor's degree in Finance from the University of Illinois
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.